• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ONLINE TDM CARBAMAZEPINE GEN 4; CARBAMAZEPINE ASSAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ONLINE TDM CARBAMAZEPINE GEN 4; CARBAMAZEPINE ASSAY Back to Search Results
Catalog Number 07258135190
Device Problems High Test Results (2457); Device Markings/Labelling Problem (2911)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/22/2022
Event Type  malfunction  
Event Description
The initial reporter received questionable carb4 (carbamazepine) results for one patient tested on a cobas 8000 c 702 module serial number (b)(4).The patient's initial carbamazepine result was reported outside the laboratory.The patient's physician questioned the reported result since the patient does not take the drug.The physician requested the sample to be tested at a different laboratory.The customer sent the patient's sample to a different laboratory to be tested on an unknown analyzer.The patient's carbamazepine result on the c 702 module was 2.1 mg/l.The patient's carbamazepine result at the different laboratory was <0.40 ug/ml.
 
Manufacturer Narrative
The investigation is ongoing.
 
Manufacturer Narrative
The analyzer used for testing at the different laboratory was an with attelica.The customer confirmed the negative result, "<0.40" ug/ml, was confirmed with chromatography and spectrometry.The patient's sample was provided for an investigation.The investigation tested the patient's sample and the sample had a levetiracetam concentration of 810 ug/ml and no interference against a component of the reagent was detected.Updated medwatch field: d4 - serial no.
 
Manufacturer Narrative
Based on the provided information, the investigation did not identify a product problem.The cause of the event could not be determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ONLINE TDM CARBAMAZEPINE GEN 4
Type of Device
CARBAMAZEPINE ASSAY
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key14110496
MDR Text Key298796293
Report Number1823260-2022-01041
Device Sequence Number1
Product Code KLT
Combination Product (y/n)N
Reporter Country CodeBE
PMA/PMN Number
K151578
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date 06/16/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/14/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number07258135190
Device Lot NumberASKU
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/24/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
KEPPRA (LEVETIRACETAM); VALPROIC ACID
-
-